[go: up one dir, main page]

DE69916266D1 - Prostaglandine und benzylalcohol enthaltende lösung - Google Patents

Prostaglandine und benzylalcohol enthaltende lösung

Info

Publication number
DE69916266D1
DE69916266D1 DE69916266T DE69916266T DE69916266D1 DE 69916266 D1 DE69916266 D1 DE 69916266D1 DE 69916266 T DE69916266 T DE 69916266T DE 69916266 T DE69916266 T DE 69916266T DE 69916266 D1 DE69916266 D1 DE 69916266D1
Authority
DE
Germany
Prior art keywords
benzyl alcohol
prostaglandine
containing solution
alcohol containing
new formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916266T
Other languages
English (en)
Other versions
DE69916266T2 (de
Inventor
G Re
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE69916266D1 publication Critical patent/DE69916266D1/de
Application granted granted Critical
Publication of DE69916266T2 publication Critical patent/DE69916266T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69916266T 1998-06-17 1999-06-08 Prostaglandine und benzylalcohol enthaltende lösung Expired - Lifetime DE69916266T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/094,985 US6187818B1 (en) 1998-06-17 1998-06-17 Prostaglandins formulation and process
US94985 1998-06-17
PCT/US1999/011808 WO1999065527A1 (en) 1998-06-17 1999-06-08 Solution comprising prostaglandins and benzyl alcohol

Publications (2)

Publication Number Publication Date
DE69916266D1 true DE69916266D1 (de) 2004-05-13
DE69916266T2 DE69916266T2 (de) 2005-03-10

Family

ID=22248341

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916266T Expired - Lifetime DE69916266T2 (de) 1998-06-17 1999-06-08 Prostaglandine und benzylalcohol enthaltende lösung

Country Status (15)

Country Link
US (1) US6187818B1 (de)
EP (1) EP1085907B1 (de)
JP (1) JP4472175B2 (de)
KR (1) KR100608176B1 (de)
CN (1) CN1188170C (de)
AT (1) ATE263576T1 (de)
AU (1) AU752047B2 (de)
CA (1) CA2331284C (de)
DE (1) DE69916266T2 (de)
DK (1) DK1085907T3 (de)
ES (1) ES2219036T3 (de)
HK (1) HK1036413A1 (de)
NZ (1) NZ508947A (de)
PT (1) PT1085907E (de)
WO (1) WO1999065527A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1350521A (zh) 1999-03-05 2002-05-22 宝洁公司 C16不饱和的fp选择性前列腺素类似物
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
CN108078998B (zh) * 2017-11-23 2018-09-21 宁波三生生物科技有限公司 一种氨基丁三醇前列腺素F2α注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885041A (en) * 1970-12-28 1975-05-20 Searle & Co Antiinflammatory use of prostaglandins
US3917864A (en) 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
US3903297A (en) 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
EP0268066A3 (de) 1986-10-17 1990-07-11 Syntex (U.S.A.) Inc. Fertilitäts-Kontrolle und Uterin-Therapie bei Hunden mit LHRH-Antagonisten
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Also Published As

Publication number Publication date
NZ508947A (en) 2003-05-30
ES2219036T3 (es) 2004-11-16
EP1085907A1 (de) 2001-03-28
CA2331284A1 (en) 1999-12-23
ATE263576T1 (de) 2004-04-15
AU752047B2 (en) 2002-09-05
CN1301178A (zh) 2001-06-27
CN1188170C (zh) 2005-02-09
EP1085907B1 (de) 2004-04-07
CA2331284C (en) 2009-09-22
KR20010052944A (ko) 2001-06-25
US6187818B1 (en) 2001-02-13
KR100608176B1 (ko) 2006-08-04
JP2002518348A (ja) 2002-06-25
PT1085907E (pt) 2004-08-31
DE69916266T2 (de) 2005-03-10
AU5079699A (en) 2000-01-05
DK1085907T3 (da) 2004-06-21
JP4472175B2 (ja) 2010-06-02
HK1036413A1 (en) 2002-01-04
WO1999065527A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
NO20054324L (no) Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning
DE69608896D1 (de) Zubereitungen enthaltend leflunomide
PL319603A1 (en) Stable aqueous alpha interferon preparations
ES2130420T3 (es) Preparado transdermico de sustancia activa.
NZ332625A (en) Concentrated antibody preparation containing greater than 100 mg/ml of the antibody
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
DK0871476T3 (da) Tørret blodfaktorpræparat indeholdende trehalose
SE9800729D0 (sv) New topical formulation I
ATE201988T1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4- benzochinon
DE69916266D1 (de) Prostaglandine und benzylalcohol enthaltende lösung
FI910112A0 (fi) Preparat foer lokalt bruk.
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
DK0647129T3 (da) Præparat til topisk anvendelse
AU618896B2 (en) Stable solutions of rebeccamycin analog and preparation thereof
EP1297838A4 (de) Pralmorelin-haltige nasentropfen-präparate
IT1250658B (it) Composizioni farmaceutiche utilizzabili in gastroenterologia
IT8711767V0 (it) Sedia per l'uso dei servizi igienici da parte di invalidi.
MX174642B (es) Formulaciones farmaceuticas
UA33259A (uk) Крем для ніг "багіра"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition